About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

NCT00106054·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

ECOG performance status of 0 or 1
Histological documentation of adenocarcinoma of the colon or rectum. The primary site must have been confirmed to be in the large bowel

You may not be if

Prior systemic anticancer therapy for mCRC
Prior hepatic surgery, chemoembolization, hepatic artery infusion, radiofrequency ablation or cryotherapy for liver metastases

The record

StatusTerminated

PhasePhase 2

Taking part2

StartedJan 2006

UpdatedAug 27, 2010

Conditions

Colorectal Neoplasms Liver Neoplasms

Where2

Pfizer Investigational Site
New York, New York, United States
Pfizer Investigational Site
Philadelphia, Pennsylvania, United States

Clareo Health | Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases